Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 9150402, 11 pages
https://doi.org/10.1155/2017/9150402
Research Article

Expression, Mutation, and Amplification Status of EGFR and Its Correlation with Five miRNAs in Salivary Gland Tumours

1Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Zaloška Cesta 4, 1000 Ljubljana, Slovenia
2Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Zaloška Cesta 2, 1000 Ljubljana, Slovenia
3Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia

Correspondence should be addressed to Metka Volavšek; is.jl-inu.fm@kesvalov.aktem

Received 14 October 2016; Revised 9 January 2017; Accepted 23 January 2017; Published 9 March 2017

Academic Editor: Gang Liu

Copyright © 2017 Emanuela Boštjančič et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Ettl, K. Baader, C. Stiegler et al., “Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer,” British Journal of Cancer, vol. 106, no. 4, pp. 719–726, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. T. S. Clauditz, A. Gontarewicz, P. Lebok et al., “Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target,” Oral Oncology, vol. 48, no. 10, pp. 991–996, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Vidal, M. S. Tsao, G. R. Pond et al., “Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib,” Head and Neck, vol. 31, no. 8, pp. 1006–1012, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Vogelstein and K. W. Kinzler, “Cancer genes and the pathways they control,” Nature Medicine, vol. 10, no. 8, pp. 789–799, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. R. P. Alexander, G. Fang, J. Rozowsky, M. Snyder, and M. B. Gerstein, “Annotating non-coding regions of the genome,” Nature Reviews Genetics, vol. 11, no. 8, pp. 559–571, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. R. H. W. Simpson, A. Skálová, S. Di Palma, and I. Leivo, “Recent advances in the diagnostic pathology of salivary carcinomas,” Virchows Archiv, vol. 465, no. 4, pp. 371–384, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. R. W. Carthew and E. J. Sontheimer, “Origins and mechanisms of miRNAs and siRNAs,” Cell, vol. 136, no. 4, pp. 642–655, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Esteller, “Non-coding RNAs in human disease,” Nature Reviews Genetics, vol. 12, no. 12, pp. 861–874, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. E. Williams, “Functional aspects of animal microRNAs,” Cellular and Molecular Life Sciences, vol. 65, no. 4, pp. 545–562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Gaur, D. A. Jewell, Y. Liang et al., “Characterization of microRNA expression levels and their biological correlates in human cancer cell lines,” Cancer Research, vol. 67, no. 6, pp. 2456–2468, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. I. Chiosea, E. L. Barnes, S. Y. Lai et al., “Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer expression,” Virchows Archiv, vol. 452, no. 6, pp. 629–635, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Zhang, M. Cairns, B. Rose et al., “Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland,” International Journal of Cancer, vol. 124, no. 12, pp. 2855–2863, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Tao, D. Wu, B. Xu et al., “microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor,” Oncology Reports, vol. 27, no. 6, pp. 1967–1975, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Liu, X. Shao, W. Gao et al., “MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor,” FEBS Journal, vol. 279, no. 20, pp. 3800–3812, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. L. H. Sobin, C. Wittekind, and International Union against Cancer, TNM Classification of Malignant Tumours, Wiley-Liss, New York, NY, USA, 6th edition, 2002.
  16. H. Kato, T. Arao, K. Matsumoto et al., “Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma,” International Journal of Oncology, vol. 42, no. 4, pp. 1151–1158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Chen, W. Zhu, D. Shi et al., “MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2,” Oncology Reports, vol. 23, no. 4, pp. 997–1003, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. G. J. Latham, “Normalization of microRNA quantitative RT-PCR data in reduced scale experimental designs,” Methods in Molecular Biology, vol. 667, pp. 19–31, 2010. View at Google Scholar
  19. T. Ettl, M. Gosau, G. Brockhoff et al., “Predictors of cervical lymph node metastasis in salivary gland cancer,” Head and Neck, vol. 36, no. 4, pp. 517–523, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Ramachandran, V. Ganapathy, E. Gillies et al., “Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence,” Cell Death & Disease, vol. 5, Article ID e1246, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Qin, P. Dong, C. Ma et al., “MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways,” Oncogene, vol. 31, no. 36, pp. 4067–4075, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. F. E. Nicolas, H. Pais, F. Schwach et al., “Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140,” RNA, vol. 14, no. 12, pp. 2513–2520, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Cros, E. Sbidian, S. Hans et al., “Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours,” Annals of Oncology, vol. 24, no. 10, pp. 2624–2629, 2013. View at Publisher · View at Google Scholar · View at Scopus